Connect with us

Bioengineer

Legendary licenses

Avatar

Published

on

ALBUQUERQUE, N.M. — Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

The consortium, a network that honors significant technology transfer accomplishments among more than 300 federal laboratories and research centers, recognized Westervelt at a virtual award ceremony earlier this month. Among his many achievements recognized by the consortium are several creative licenses for New Mexico tech companies and an innovative license prioritization procedure for Sandia.

“Bob came to Sandia with a unique set of knowledge and skills in science, business and licensing, which is perfect for his current role,” said Joel Sikora, Sandia manager of technology partnership agreements. “He’s a valuable staff member, and as an expert in software, patents and licensing, he’s helped us think critically in terms of impact when it comes to technology, so that businesses ideally get the best return on investment when they manufacture and distribute products and services that often have the potential to increase national security or benefit the economy.”

License successes boost Sandia’s mission, NM economy

Westervelt was instrumental in licensing the X-Ray Toolkit, or XTK, an image-processing and analysis software developed at Sandia that is used by the military, bomb squads and emergency response teams. Technicians use the software with scanners to look inside and analyze suspicious objects. Westervelt said Sandia offers the software to military and law enforcement for free. In addition, no-cost test and evaluation licenses were provided to X-ray scanner manufacturers so they could make sure XTK worked with their hardware. Companies willing to give high-quality training to end users could also obtain low-cost licenses.

“The X-Ray Toolkit was always one that I’ve been particularly proud of,” he said. “Thousands of people are using XTK all across the United States, and in the last few years, it’s been transitioning internationally. There are bomb techs all over the world who are starting to use XTK.”

Westervelt is also proud of licenses that went to New Mexico start-ups such as Eden Radioisotopes, a company working to build a reactor that will produce medical isotopes; BayoTech, a company that makes mobile hydrogen generators; and mPower, which is developing flexible solar cells smaller than the width of human hair.

“People aren’t generally aware of New Mexico’s start-up activity, but some of these companies have done really well raising money,” he said. “They’re at different stages, and we’ve been able to evolve the licenses along with how the companies have changed to make sure that they have the foundation to be successful. It will be nice to see three big, successful companies come out of the licenses.”

Concept gives priority to high-impact licenses

Westervelt also created the concept of High Value Licensing, which has been utilized at Sandia to prioritize licenses that will have the most impact. It works by analyzing potential license opportunities by those that are routine, those that are important to Sandia’s national security mission, those that could have financial return and others that are high-risk, high reward.

“As a manager, I greatly value the High Value License framework because it has improved our commercialization potential,” Sikora said. “The framework was based on an analysis of our previous years’ licensing activity and enables us to balance mission and commercial technology licenses.”

While the group looks at financial value of a license, they try to prioritize opportunities that could help national security, even if the developed technology won’t bring in a lot of money. XTK is a good example, Westervelt said, because it has domestic and international success and makes the world safer.

“The opportunities for the laboratories to work with companies through tech transfer really enables more robust solutions to come out of the laboratory, and we end up benefitting the country,” Westervelt said. “By engaging with outside partners, it gets the technical staff thinking about the broader focus on problems. Instead of solving one problem, researchers might solve multiple problems. And if solving problems helps the economy, that also helps national security.”

Interest in science, business, novel projects led to Sandia

Originally from upstate New York, Westervelt said he always had an interest in science, leading him to earn an undergraduate degree in physics and a doctorate in nuclear physics. His thesis research took him to New Mexico for research using a particle accelerator at Los Alamos National Laboratory.

Following graduation from Stanford University, Westervelt continued working on accelerator control systems at Los Alamos before leaving to join a company that licensed software from the lab to develop several types of industrial control systems.

“That gave me the experience with respect to what it takes to make a startup successful, and we had applied technology developed at the national labs for application in something that wasn’t envisioned for when it was first developed,” Westervelt said. “It’s very fulfilling when technology that you’ve been working on makes it into everyday applications and gets used broadly. We had a map of all of our customers so we could see all the places that were using it.”

After about nine years, Westervelt left to join a digital imaging company as a chief technology officer, where he combined the company’s technology with technology licensed from larger companies, then integrated the combination into customers’ printers and copiers.

“So, on one side, I was seeing what it takes to deal with licenses from big companies, and then how to license it to our customers,” he said.

Westervelt was heavily involved in negotiations when part of that company and its intellectual property sold. He found his next opportunity at Sandia in 2012.

“I was looking for interesting projects to work on as opposed to a particular venue or location. I think that’s what led me through my career path and how I ended up at Sandia,” he said, adding that the position sort of took him full circle, back to a national laboratory with a strong science and technology focus.

“Licensing at Sandia gives you the opportunity to see all of the different types of technologies, the problems that they’re applied to, and what they could be applied to in the future. I found that a particularly interesting challenge to take on.”

###

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://bioengineer.org/legendary-licenses/

Bioengineer

Dr. Marie-Claude Morice to receive the 2021 Andreas Gruntzig Ethica Award

Avatar

Published

on

Dr. Morice’s contributions to the PCR mission are to be recognised at the EuroPCR 2021 Course

EuroPCR, taking place online from 18 to 20 May 2021, will be an opportunity for the interventional cardiovascular community to come together and benefit from interactive training with their peers. At this year’s web-based event, Dr. Marie-Claude Morice will be presented with the Andreas Grüntzig Ethica Award in recognition of her contribution to training, education and clinical research in interventional cardiology.

The Andreas Grüntzig Ethica Award is presented every year to an outstanding colleague who has contributed in an extraordinary way to the PCR mission: serving the needs of every individual patient by helping the cardiovascular community to share knowledge, experience and practice. Dr. Morice, as a practitioner, researcher and mentor, is a perfect example of what PCR stands for and is a very deserving recipient of this year’s award. The ceremony will take place on Thursday 20 May at 11.45 a.m. Paris time on the Main Arena channel.

A practitioner and clinical scientist

Dr. Marie-Claude Morice has been chosen as the recipient of this year’s award in recognition of her work as a leading researcher and practitioner in interventional cardiology, with an impressive career spanning over four decades. This award recognises four visionary contributions of Marie-Claude Morice’s research to the practice of interventional cardiology that have had an enormous impact on patient well-being:

  • Pioneering the use of the antiplatelet drug clopidogrel to prevent acute and chronic thrombosis further to Percutaneous Coronary Intervention (PCI), with or without the use of a stent, to replace multiple ineffective anticoagulants.
  • Contributing to the validation and adoption of active drug-eluting stents in daily practice as principal investigator in many trials, including the very first trial – the RAVEL study.
  • Extending PCI indications to multivessel coronary artery disease and especially left main coronary artery disease, thus far wrongly considered as a “no touch” lesion subset for interventionalists.
  • Identifying an “orphan” group of patients with High Bleeding Risk (HBR) and establishing the boundaries of targeted antiplatelet therapy through dedicated trials in order to reduce bleeding without increasing ischaemic risk.

Contribution to the learning continuum

Dr. Marie-Claude Morice has shown great commitment to educating and training, with a special focus on young professionals. As part of her determination to help others learn and practice, she was involved in the creation of the PCR Clinical Research programme, which is open to all stakeholders of the clinical research process. She is the woman behind the creation of the PCR Tokyo Valves Course, enlisting the dedicated commitment and leadership of Dr Saito-san and Dr Kentaro Hayashida, one of her pupils. Through these initiatives, Marie-Claude has embraced PCR’s mission, sharing her knowledge, experience and practice in cardiovascular interventional medicine to help younger generations of practitioners get a foot on the ladder. Her commitment has been invaluable to many of her young colleagues, including Davide Capodanno, Christopher Cook, Dejan Milasinovich and Kentaro Hayashida through PCR Clinical Research and PCR Tokyo Valves.

An advocate for gender equality

Dr. Morice has been and remains a key player in the fight for gender equality. Her combat has targeted society at large and, of course, the world of interventional cardiology, with a special focus on patients. She has notably conducted research studying the impact of gender on access to care and the differential outcomes of therapies. She firmly believes that women have a place in the field of medicine and co-founded Women as One, an initiative that promotes talent in medicine and cardiology by providing unique professional opportunities to female physicians.

###

NOTES TO EDITORS

Dates to remember

  • EuroPCR Course – 18-20 May 2021 – Livestream programme
  • Andreas Grüntzig Ethica Award – 20 May 2021, 11.45 a.m. Paris time – Main Arena channel

About EuroPCR 2021

The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place online from 18 to 20 May 2021. In this virtual course, the interventional cardiovascular community will come together to share knowledge, skills and experience to provide better care for patients around the world. This year will offer new interactive ways of learning.

The detailed Interactive Programme is available here.

About PCR

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a broad range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual courses across the globe, e-Learning with high-profile PCR webinars, courses specifically dedicated to valvular heart disease, tailor-made PCR seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

Gateways to all PCR activities are available at http://www.pcronline.com

For more information, please contact Célia Vila: [email protected]

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://bioengineer.org/dr-marie-claude-morice-to-receive-the-2021-andreas-gruntzig-ethica-award/

Continue Reading

Bioengineer

Dr. Marie-Claude Morice to receive the 2021 Andreas Gruntzig Ethica Award

Avatar

Published

on

Dr. Morice’s contributions to the PCR mission are to be recognised at the EuroPCR 2021 Course

EuroPCR, taking place online from 18 to 20 May 2021, will be an opportunity for the interventional cardiovascular community to come together and benefit from interactive training with their peers. At this year’s web-based event, Dr. Marie-Claude Morice will be presented with the Andreas Grüntzig Ethica Award in recognition of her contribution to training, education and clinical research in interventional cardiology.

The Andreas Grüntzig Ethica Award is presented every year to an outstanding colleague who has contributed in an extraordinary way to the PCR mission: serving the needs of every individual patient by helping the cardiovascular community to share knowledge, experience and practice. Dr. Morice, as a practitioner, researcher and mentor, is a perfect example of what PCR stands for and is a very deserving recipient of this year’s award. The ceremony will take place on Thursday 20 May at 11.45 a.m. Paris time on the Main Arena channel.

A practitioner and clinical scientist

Dr. Marie-Claude Morice has been chosen as the recipient of this year’s award in recognition of her work as a leading researcher and practitioner in interventional cardiology, with an impressive career spanning over four decades. This award recognises four visionary contributions of Marie-Claude Morice’s research to the practice of interventional cardiology that have had an enormous impact on patient well-being:

  • Pioneering the use of the antiplatelet drug clopidogrel to prevent acute and chronic thrombosis further to Percutaneous Coronary Intervention (PCI), with or without the use of a stent, to replace multiple ineffective anticoagulants.
  • Contributing to the validation and adoption of active drug-eluting stents in daily practice as principal investigator in many trials, including the very first trial – the RAVEL study.
  • Extending PCI indications to multivessel coronary artery disease and especially left main coronary artery disease, thus far wrongly considered as a “no touch” lesion subset for interventionalists.
  • Identifying an “orphan” group of patients with High Bleeding Risk (HBR) and establishing the boundaries of targeted antiplatelet therapy through dedicated trials in order to reduce bleeding without increasing ischaemic risk.

Contribution to the learning continuum

Dr. Marie-Claude Morice has shown great commitment to educating and training, with a special focus on young professionals. As part of her determination to help others learn and practice, she was involved in the creation of the PCR Clinical Research programme, which is open to all stakeholders of the clinical research process. She is the woman behind the creation of the PCR Tokyo Valves Course, enlisting the dedicated commitment and leadership of Dr Saito-san and Dr Kentaro Hayashida, one of her pupils. Through these initiatives, Marie-Claude has embraced PCR’s mission, sharing her knowledge, experience and practice in cardiovascular interventional medicine to help younger generations of practitioners get a foot on the ladder. Her commitment has been invaluable to many of her young colleagues, including Davide Capodanno, Christopher Cook, Dejan Milasinovich and Kentaro Hayashida through PCR Clinical Research and PCR Tokyo Valves.

An advocate for gender equality

Dr. Morice has been and remains a key player in the fight for gender equality. Her combat has targeted society at large and, of course, the world of interventional cardiology, with a special focus on patients. She has notably conducted research studying the impact of gender on access to care and the differential outcomes of therapies. She firmly believes that women have a place in the field of medicine and co-founded Women as One, an initiative that promotes talent in medicine and cardiology by providing unique professional opportunities to female physicians.

###

NOTES TO EDITORS

Dates to remember

  • EuroPCR Course – 18-20 May 2021 – Livestream programme
  • Andreas Grüntzig Ethica Award – 20 May 2021, 11.45 a.m. Paris time – Main Arena channel

About EuroPCR 2021

The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place online from 18 to 20 May 2021. In this virtual course, the interventional cardiovascular community will come together to share knowledge, skills and experience to provide better care for patients around the world. This year will offer new interactive ways of learning.

The detailed Interactive Programme is available here.

About PCR

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a broad range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual courses across the globe, e-Learning with high-profile PCR webinars, courses specifically dedicated to valvular heart disease, tailor-made PCR seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

Gateways to all PCR activities are available at http://www.pcronline.com

For more information, please contact Célia Vila: [email protected]

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://bioengineer.org/dr-marie-claude-morice-to-receive-the-2021-andreas-gruntzig-ethica-award/

Continue Reading

Bioengineer

Commencement of full operation of research data management platform “GakuNin RDM”

Avatar

Published

on

to support management/sharing of research data among Japanese academic institutions nationwide

NII developed GakuNin RDM in response to the Japanese government’s policy on science and technology, as well as the international trend toward open science. The GakuNin RDM service supports researchers’ data management, from daily research activities in the laboratory to publicly funded research projects. In addition to enabling collaborators to manage and share data across organizations, the service can also be linked with various cloud services and research software.

From another perspective, GakuNin RDM is expected to suppress operations that lead to research misconduct owing to a trail management function to record the operation history of research data saved in the system. By preventing research misconduct before research results are published, and by serving as a starting point for research data to be properly published and discovered, GakuNin RDM can support the future development of open science.

GakuNin RDM
https://rdm.nii.ac.jp

In recent years, the importance of data has been increasing in industries as well as in academic fields. The proper management of research data is important for effectively conducting research projects and increasing the transparency of the processes through which results are obtained. Moreover, in today’s academic research, which has become highly complex, researchers are required to conduct interdisciplinary research and industry-academia collaborative research with speed and efficiency. As shown by the fact that Japan’s science and technology policy (Cabinet of Japan Integrated Innovation Strategy 2020 *2) includes goals such as “promotion of advanced data management, including the use of research data generated by publicly funded research activities,” the need for a nationwide research data platform has begun to increase.

To meet these new academic demands, since April 2017, the National Institute of Informatics (NII) has been building a new service called GakuNin RDM to support research data management. Necessary functions have been continually expanded in the demonstration experiments that began in January 2019, and GakuNin RDM’s full-scale operation for universities and research institutes began on February 15th, 2021.

For more information about this service, please refer to the Information on application for use page.

Information on application for use
https://meatwiki.nii.ac.jp/confluence/display/gakuninrdmusers

GakuNin RDM enables research data to be quickly managed and shared by multiple researchers across organizations. Thus, in addition to being used for individual research activities, it can serve as a hub for joint research, and used flexibly for research projects of various sizes and fields. Moreover, it is highly scalable and can be linked with cloud storage and external tools that are often used by researchers. GakuNin RDM also partakes in the Academic Access Management Federation in Japan (GakuNin)*3, and allows users to log in to the same environment as usual and use the service even while teleworking or during business trips.

GakuNin RDM features a trail management function that uses time stamps from a third-party time authentication authority, allowing one to prove that the data stored in a system existed at a particular time. This is also a powerful function from the perspective of research integrity. For academic institutions, centralized management of research data on a common infrastructure system can be expected to enhance the data governance of academic institutions. Institutions with GakuNin membership can easily introduce the service to their organization by applying for use and linking access management systems.

Figure 1 shows an example of multiple research groups using GakuNin RDM for research data management and sharing. GakuNin RDM also allows principal investigators to manage the projects conducted by different groups in a list form.

###

About the Research Organization of Information and Systems (ROIS)

ROIS is a parent organization of four national institutes (National Institute of Polar Research, National Institute of Informatics, the Institute of Statistical Mathematics and National Institute of Genetics) and the Joint Support-Center for Data Science Research. It is ROIS’s mission to promote integrated, cutting-edge research that goes beyond the barriers of these institutions, in addition to facilitating their research activities, as members of inter-university research institutes.

About the National Institute of Informatics (NII)

NII is Japan’s only academic research institute dedicated to the new discipline of informatics. Its mission is to “create future value” in informatics. NII conducts both long-term basic research and practical research aimed at solving social problems in a wide range of informatics research fields, from fundamental theories to the latest topics, such as artificial intelligence, big data, the Internet of Things, and information security.

As an inter-university research institute, NII builds and operates academic information infrastructure essential for the research and educational activities of the entire academic community (including the Science Information Network) as well as developing services such as those that enable the provision of academic content and service platforms.

https://www.nii.ac.jp/en/

(*1) Research Center for Open Science and Data Platform: In response to the global momentum toward open science, this research center was established within NII in April 2017, in order to develop and operate an academic platform that could serve as an infrastructure for open science. It is expected that, through the wide sharing of academic papers and research data in academia and society, and a wide range of research activities being carried out openly, research activities will be accelerated, problem solving based on close cooperation with society will be promoted, and that this will push academic activities to a new dimension (open science).

See https://rcos.nii.ac.jp/en/ for details.

(*2) Cabinet of Japan Integrated Innovation Strategy 2020:

https://www8.cao.go.jp/cstp/english/

(*3) Academic Access Management Federation in Japan (GakuNin): The Academic Access Management Federation in Japan is a federation consisting of universities that use academic e-resources and the institutions, publishers, etc., that provide these e-resources. By trusting the policies of the federation, institutions are able to realize mutual cooperation with regard to access management.

See https://www.gakunin.jp/en for details.

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://bioengineer.org/commencement-of-full-operation-of-research-data-management-platform-gakunin-rdm/

Continue Reading

Bioengineer

Commencement of full operation of research data management platform “GakuNin RDM”

Avatar

Published

on

to support management/sharing of research data among Japanese academic institutions nationwide

NII developed GakuNin RDM in response to the Japanese government’s policy on science and technology, as well as the international trend toward open science. The GakuNin RDM service supports researchers’ data management, from daily research activities in the laboratory to publicly funded research projects. In addition to enabling collaborators to manage and share data across organizations, the service can also be linked with various cloud services and research software.

From another perspective, GakuNin RDM is expected to suppress operations that lead to research misconduct owing to a trail management function to record the operation history of research data saved in the system. By preventing research misconduct before research results are published, and by serving as a starting point for research data to be properly published and discovered, GakuNin RDM can support the future development of open science.

GakuNin RDM
https://rdm.nii.ac.jp

In recent years, the importance of data has been increasing in industries as well as in academic fields. The proper management of research data is important for effectively conducting research projects and increasing the transparency of the processes through which results are obtained. Moreover, in today’s academic research, which has become highly complex, researchers are required to conduct interdisciplinary research and industry-academia collaborative research with speed and efficiency. As shown by the fact that Japan’s science and technology policy (Cabinet of Japan Integrated Innovation Strategy 2020 *2) includes goals such as “promotion of advanced data management, including the use of research data generated by publicly funded research activities,” the need for a nationwide research data platform has begun to increase.

To meet these new academic demands, since April 2017, the National Institute of Informatics (NII) has been building a new service called GakuNin RDM to support research data management. Necessary functions have been continually expanded in the demonstration experiments that began in January 2019, and GakuNin RDM’s full-scale operation for universities and research institutes began on February 15th, 2021.

For more information about this service, please refer to the Information on application for use page.

Information on application for use
https://meatwiki.nii.ac.jp/confluence/display/gakuninrdmusers

GakuNin RDM enables research data to be quickly managed and shared by multiple researchers across organizations. Thus, in addition to being used for individual research activities, it can serve as a hub for joint research, and used flexibly for research projects of various sizes and fields. Moreover, it is highly scalable and can be linked with cloud storage and external tools that are often used by researchers. GakuNin RDM also partakes in the Academic Access Management Federation in Japan (GakuNin)*3, and allows users to log in to the same environment as usual and use the service even while teleworking or during business trips.

GakuNin RDM features a trail management function that uses time stamps from a third-party time authentication authority, allowing one to prove that the data stored in a system existed at a particular time. This is also a powerful function from the perspective of research integrity. For academic institutions, centralized management of research data on a common infrastructure system can be expected to enhance the data governance of academic institutions. Institutions with GakuNin membership can easily introduce the service to their organization by applying for use and linking access management systems.

Figure 1 shows an example of multiple research groups using GakuNin RDM for research data management and sharing. GakuNin RDM also allows principal investigators to manage the projects conducted by different groups in a list form.

###

About the Research Organization of Information and Systems (ROIS)

ROIS is a parent organization of four national institutes (National Institute of Polar Research, National Institute of Informatics, the Institute of Statistical Mathematics and National Institute of Genetics) and the Joint Support-Center for Data Science Research. It is ROIS’s mission to promote integrated, cutting-edge research that goes beyond the barriers of these institutions, in addition to facilitating their research activities, as members of inter-university research institutes.

About the National Institute of Informatics (NII)

NII is Japan’s only academic research institute dedicated to the new discipline of informatics. Its mission is to “create future value” in informatics. NII conducts both long-term basic research and practical research aimed at solving social problems in a wide range of informatics research fields, from fundamental theories to the latest topics, such as artificial intelligence, big data, the Internet of Things, and information security.

As an inter-university research institute, NII builds and operates academic information infrastructure essential for the research and educational activities of the entire academic community (including the Science Information Network) as well as developing services such as those that enable the provision of academic content and service platforms.

https://www.nii.ac.jp/en/

(*1) Research Center for Open Science and Data Platform: In response to the global momentum toward open science, this research center was established within NII in April 2017, in order to develop and operate an academic platform that could serve as an infrastructure for open science. It is expected that, through the wide sharing of academic papers and research data in academia and society, and a wide range of research activities being carried out openly, research activities will be accelerated, problem solving based on close cooperation with society will be promoted, and that this will push academic activities to a new dimension (open science).

See https://rcos.nii.ac.jp/en/ for details.

(*2) Cabinet of Japan Integrated Innovation Strategy 2020:

https://www8.cao.go.jp/cstp/english/

(*3) Academic Access Management Federation in Japan (GakuNin): The Academic Access Management Federation in Japan is a federation consisting of universities that use academic e-resources and the institutions, publishers, etc., that provide these e-resources. By trusting the policies of the federation, institutions are able to realize mutual cooperation with regard to access management.

See https://www.gakunin.jp/en for details.

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://bioengineer.org/commencement-of-full-operation-of-research-data-management-platform-gakunin-rdm/

Continue Reading
AI5 days ago

Build a cognitive search and a health knowledge graph using AWS AI services

Esports4 days ago

‘Destroy Sandcastles’ in Fortnite Locations Explained

Blockchain4 days ago

Shiba Inu: Know How to Buy the New Dogecoin Rival

Blockchain5 days ago

Meme Coins Craze Attracting Money Behind Fall of Bitcoin

Esports5 days ago

Valve launches Supporters Clubs, allows fans to directly support Dota Pro Circuit teams

Blockchain5 days ago

Sentiment Flippening: Why This Bitcoin Expert Doesn’t Own Ethereum

Blockchain4 days ago

Texas House Passes Bill that Recognizes Crypto Under Commercial Law

Aviation4 days ago

American Airlines Continues To Build Up Its Core Hub Strategy

Aviation5 days ago

Reuters: American Airlines adds stops to two flights after pipeline outage

ACN Newswire5 days ago

Duet Protocol closes first-round funding at US$3 million

Cyber Security5 days ago

Pending Data Protection and Security Laws At-A-Glance: APAC

AI5 days ago

Onestream: Data analysis, AI tools usage increased in 2021

Blockchain5 days ago

QAN Raises $2.1 Million in Venture Capital to Build DeFi Ecosystem

Blockchain4 days ago

Facebook’s Diem Enters Crypto Space With Diem USD Stablecoin

Business Insider5 days ago

Rally Expected To Stall For China Stock Market

Blockchain4 days ago

NSAV ANNOUNCES LAUNCH OF VIRTUABROKER’S PROPRIETARY CRYPTOCURRENCY PRICE SEARCH FEATURE

Esports4 days ago

Video: s1mple – MVP of DreamHack Masters Spring 2021

Business Insider4 days ago

HDI Announces Voting Results for Annual General and Special Meeting

AR/VR1 day ago

Next Dimension Podcast – Pico Neo 3, PSVR 2, HTC Vive Pro 2 & Vive Focus 3!

Esports4 days ago

TiMi Studios partners with Xbox Game Studios to bring a “new game sensory experience” to players

Trending